CGVVX Mutual Fund

NAV$15.72

Fund Essentials - as of Dec 31, 2025

Net Assets
$14M
Expense Ratio
1.10%
Dividend Yield (Current)
9.26%
Holdings
55
Inception Date
Jan 31, 2011
Fund Family
Causeway Capital Management
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+3.83%
1 Year+23.72%
3 Year+20.08%
5 Year+13.02%
10 Year+11.94%

Asset Allocation

Stocks: 98.67%
Cash: 1.34%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
KER:PAKering Sa4.44%
6723:JPRenesas Electronics Corp. Com Stk3.47%
ALSO:PAAlstom3.30%
AZN:LNAstraZeneca PLC3.04%
005930:KRSamsung Electronics (Equity)2.93%
Top 10 Concentration: 30.70%Report Date: Dec 31, 2025
Download all 55 holdings for CGVVX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
9.26%
Frequency
Annually
Latest Distribution
$0.14
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

CGVVX Mutual Fund Overview

CGVVX Mutual Fund (Causeway Global Value Fund Investor Class) is managed by Causeway Capital Management with $13.7M in net assets. CGVVX expense ratio is 1.10%, holding 55 positions across sectors including Unknown, Information Technology, Financials. Inception date: 2011-01-31.

CGVVX performance shows a YTD return of 3.83%. The 1-year return is 23.72% and the 5-year return is 13.02%. CGVVX dividend yield stands at 9.26%, paid annually.

CGVVX top holdings include Kering Sa (4.4%), Renesas Electronics Corp. Com Stk (3.5%), Alstom (3.3%), AstraZeneca PLC (3.0%), Samsung Electronics (Equity) (2.9%). View all CGVVX holdings, sector breakdown, or dividend history.

CGVVX can be compared against other funds using the overlap calculator or side-by-side comparison tool. CGVVX alternatives are available via the screener, along with tax-loss harvesting opportunities.